CD19-targeting CAR T-cell immunotherapy yields high responses in treatment-resistant CLL

In a small, early phase trial, a high percentage of patients who had exhausted most traditional treatments for chronic lymphocytic leukemia saw their tumors shrink or even disappear after an infusion of a highly targeted, experimental CAR T-cell immunotherapy.
Source: ScienceDaily Headlines - Category: Science Source Type: news